BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18097237)

  • 1. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
    Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
    AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.
    Cuzin L; Delpierre C; Gerard S; Massip P; Marchou B
    Clin Infect Dis; 2007 Sep; 45(5):654-7. PubMed ID: 17683004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structured interruptions of therapy: looking for the best protocol.
    Aiuti F; Giovannetti A
    AIDS; 2003 Oct; 17(15):2257-8. PubMed ID: 14523284
    [No Abstract]   [Full Text] [Related]  

  • 4. Stopping antiretroviral therapy: easier said than done.
    Hull M; Harris M; Montaner JS
    AIDS; 2007 Aug; 21(13):1817-8. PubMed ID: 17690582
    [No Abstract]   [Full Text] [Related]  

  • 5. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
    Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
    HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
    [No Abstract]   [Full Text] [Related]  

  • 6. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early versus deferred antiretroviral therapy for HIV.
    Gelinck LB; van der Ende ME
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV-1 protease inhibitors: cell metabolism and drug resistance (review)].
    Bobkova MR
    Ter Arkh; 2008; 80(10):77-80. PubMed ID: 19105421
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic drug monitoring in HIV disease.
    Hoetelmans R; Miller V
    J HIV Ther; 2001 Aug; 6(3):65-7. PubMed ID: 11547263
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiretroviral therapy suppression: already a new strategy?].
    Viciana Fernández P; Mata Alcázar-Caballero R; López Cortés LF
    Farm Hosp; 2004; 28(6 Suppl 1):85-91. PubMed ID: 15649120
    [No Abstract]   [Full Text] [Related]  

  • 11. Stopping antiretroviral therapy.
    Taylor S; Boffito M; Khoo S; Smit E; Back D
    AIDS; 2007 Aug; 21(13):1673-82. PubMed ID: 17690564
    [No Abstract]   [Full Text] [Related]  

  • 12. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

  • 13. Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents.
    Winston A; Garvey L; Sabin CA
    AIDS; 2011 Apr; 25(7):1014-5. PubMed ID: 21487256
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics in HAART and antibiotic therapy.
    Boffito M
    New Microbiol; 2007 Jul; 30(3):346-9. PubMed ID: 17802923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of serum levels of antiretroviral drugs].
    Kurowski M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053
    [No Abstract]   [Full Text] [Related]  

  • 16. When to start antiretroviral therapy--ready when you are?
    Sax PE; Baden LR
    N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral drug concentrations in the male and female genital tract: implications for the sexual transmission of HIV.
    Taylor S; Davies S
    Curr Opin HIV AIDS; 2010 Jul; 5(4):335-43. PubMed ID: 20543610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 30 years after HIV identification: where to from here?
    Stover J
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):947-9. PubMed ID: 22029511
    [No Abstract]   [Full Text] [Related]  

  • 19. Ask the experts.
    Kaiser JD
    Explore (NY); 2006; 2(5):471-2. PubMed ID: 16979115
    [No Abstract]   [Full Text] [Related]  

  • 20. Baseline antiretroviral resistance and clinical outcomes in an urban HIV clinic.
    Klibanov OM; Dolder CR; Assefa F; Ekwonu TJ
    AIDS Patient Care STDS; 2013 Apr; 27(4):205-7. PubMed ID: 23514132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.